BENJAMIN TSCHUDY: Open Payments
NPI 1821749391 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 80 payments from 13 companies in 2025. Trend: 2023 $645 · 2024 $1,192 · 2025 $1,359
Food & beverage: $1,259Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 24 | $273 |
| GENZYME CORPORATION | 9 | $241 |
| Janssen Biotech, Inc. | 13 | $212 |
| UCB, Inc. | 8 | $183 |
| Amgen Inc. | 7 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Lilly USA, LLC | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Organon LLC | 3 | $35 |
| ABBVIE INC. | 2 | $34 |
Products named: OPZELURA, DUPIXENT, TREMFYA, Bimzelx, Otezla, TALTZ, COSENTYX, Sotyktu.
Industry payments across NM — which companies pay providers there.
